Referências
Principais artigos
Dowell D, Ragan KR, Jones CM, et al. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022 Nov 4;71(3):1-95.Texto completo Resumo
Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Evidence-based strategies for preventing opioid overdose: what’s working in the United States. 22 October 2020 [internet publication].Texto completo
Dezfulian C, Orkin AM, Maron BA, et al. Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for health care and public responses: a scientific statement from the American Heart Association. Circulation. 2021 Apr 20;143(16):e836-70.Texto completo Resumo
Resuscitation Council UK. 2021 resuscitation guidelines. 2021 [internet publication].Texto completo
Williams K, Lang ES, Panchal AR, et al. Evidence-based guidelines for EMS administration of naloxone. Prehosp Emerg Care. 2019 Nov-Dec;23(6):749-63.Texto completo Resumo
Lavonas EJ, Akpunonu PD, Arens AM, et al. 2023 American Heart Association focused update on the management of patients with cardiac arrest or life-threatening toxicity due to poisoning: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2023 Oct 17;148(16):e149-84.Texto completo Resumo
Artigos de referência
1. World Health Organization. Opioid overdose. 4 August 2021 [internet publication].Texto completo
2. Office for National Statistics. Census 2021 - Deaths related to drug poisoning in England and Wales: 2020 registrations. 3 August 2021 [internet publication].Texto completo
3. Drug Abuse Warning Network. The DAWN report: highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. February 2013 [internet publication].Texto completo
4. Centers for Disease Control and Prevention. Opioid overdose: understanding the epidemic. 17 March 2021 [internet publication].Texto completo
5. Centers for Disease Control and Prevention. CDC’s National Center for Health Statistics: provisional drug overdose death counts. Jul 2023 [internet publication].Texto completo
6. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):618-27. Resumo
7. Seth P, Scholl L, Rudd RA, et al. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-58.Texto completo Resumo
8. Centers for Disease Control and Prevention. Rising numbers of deaths involving fentanyl and fentanyl analogs, including carfentanil, and increased usage and mixing with non-opioids. HAN no. 413. July 2018 [internet publication].Texto completo
9. Kariisa M, Patel P, Smith H, et al. Notes from the Field: xylazine detection and involvement in drug overdose deaths - United States, 2019. MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1300-2.Texto completo Resumo
10. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison - a high risk of death for former inmates. N Engl J Med. 2007 Jan 11;356(2):157-65. Resumo
11. Anoro M, Ilundain E, Rodriguez R, et al. Factors related to experiencing respiratory failure in cases of opiate overdose for which care was provided in an open setting. Barcelona, Spain. Rev Esp Salud Publica. Sep-Oct 2004;78(5):601-8.Texto completo Resumo
12. Chang AK, Bijur PE, Esses D, et al. Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: a randomized clinical trial. JAMA. 2017 Nov 7;318(17):1661-7. Resumo
13. Dowell D, Ragan KR, Jones CM, et al. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022 Nov 4;71(3):1-95.Texto completo Resumo
14. Substance Abuse and Mental Health Services Administration (SAMHSA). Opioid overdose prevention toolkit. June 2018 [internet publication].Texto completo
15. Centers for Disease Control and Prevention. Drug overdose: prescription drug monitoring programs (PDMPs). May 2021 [internet publication].Texto completo
16. Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89-96. Resumo
17. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Evidence-based strategies for preventing opioid overdose: what’s working in the United States. 22 October 2020 [internet publication].Texto completo
18. US Department of Health and Human Services. Naloxone: the opioid reversal drug that saves lives. How healthcare providers and patients can better utilize this life-saving drug. December 2018 [internet publication].Texto completo
19. Public Health England. Widening the availability of naloxone. 18 February 2019 [internet publication].Texto completo
20. Babu KM, Brent J, Juurlink DN. Prevention of opioid overdose. N Engl J Med. 2019 Jun 6;380(23):2246-55.Texto completo Resumo
21. Sharma V, Simpson SH, Samanani S, et al. Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study. BMJ Open. 2020 Nov 20;10(11):e038692.Texto completo Resumo
22. Medicines and Healthcare products Regulatory Agency. Serious and fatal overdose of fentanyl patches. 11 December 2014 [internet publication].Texto completo
23. US Food and Drug Administration. Accidental exposures to fentanyl patches continue to be deadly to children. 21 July 2021 [internet publication].Texto completo
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th rev ed. Washington: American Psychiatric Association Publishing; 2022.
25. Dezfulian C, Orkin AM, Maron BA, et al. Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for health care and public responses: a scientific statement from the American Heart Association. Circulation. 2021 Apr 20;143(16):e836-70.Texto completo Resumo
26. Resuscitation Council UK. 2021 resuscitation guidelines. 2021 [internet publication].Texto completo
27. Hoffman JR, Schriger DL, Luo JS. The empiric use of naloxone in patients with altered mental status: a reappraisal. Ann Emerg Med. 1991 Mar;20(3):246-52. Resumo
28. Hierholzer J, Cordes M, Tantow H, et al. Drug smuggling by ingested cocaine-filled packages: conventional x-ray and ultrasound. Abdom Imaging. 1995 Jul-Aug;20(4):333-8. Resumo
29. McCarron MM, Wood JD. The cocaine 'body packer' syndrome. Diagnosis and treatment. JAMA. 1983 Sep 16;250(11):1417-20. Resumo
30. Whipple JK, Quebbeman EJ, Lewis KS, et al. Difficulties in diagnosing narcotic overdoses in hospitalized patients. Ann Pharmacother. 1994 Apr;28(4):446-50. Resumo
31. Williams K, Lang ES, Panchal AR, et al. Evidence-based guidelines for EMS administration of naloxone. Prehosp Emerg Care. 2019 Nov-Dec;23(6):749-63.Texto completo Resumo
32. Lavonas EJ, Akpunonu PD, Arens AM, et al. 2023 American Heart Association focused update on the management of patients with cardiac arrest or life-threatening toxicity due to poisoning: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2023 Oct 17;148(16):e149-84.Texto completo Resumo
33. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012 Jul 12;367(2):146-55.Texto completo Resumo
34. Mills CA, Flacke JW, Flacke WE, et al. Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine. Can J Anaesth. 1990 Mar;37(2):238-44. Resumo
35. Mills CA, Flacke JW, Miller JD, et al. Cardiovascular effects of fentanyl reversal by naloxone at varying arterial carbon dioxide tensions in dogs. Anesth Analg. 1988 Aug;67(8):730-6. Resumo
36. Thadani PV. NIDA conference report on cardiopulmonary complications of "crack" cocaine use. Clinical manifestations and pathophysiology. Chest. 1996 Oct;110(4):1072-6. Resumo
37. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1334-49. Resumo
38. Kerr D, Kelly AM, Dietze P, et al. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009 Dec;104(12):2067-74. Resumo
39. Chou R, Korthuis PT, McCarty D, et al. Management of suspected opioid overdose with naloxone in out-of-hospital settings: a systematic review. Ann Intern Med. 2017 Dec 19;167(12):867-75.Texto completo Resumo
40. Dietze P, Jauncey M, Salmon A, et al. Effect of intranasal vs intramuscular naloxone on opioid overdose: a randomized clinical trial. JAMA Netw Open. 2019 Nov 1;2(11):e1914977.Texto completo Resumo
41. Sutter ME, Gerona RR, Davis MT, et al. Fatal fentanyl: one pill can kill. Acad Emerg Med. 2017 Jan;24(1):106-13.Texto completo Resumo
42. Rogers JS, Rehrer SJ, Hoot NR. Acetylfentanyl: an emerging drug of abuse. J Emerg Med. 2016 Mar;50(3):433-6. Resumo
43. Howland MAH. Antidotes in depth opioid antagonists. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicological emergencies. 8th ed. New York, NY: McGraw-Hill; 2006:614-7.
44. van Dorp E, Yassen A, Sarton E, et al. Naloxone reversal of buprenorphine-induced respiratory depression. Anesthesiology. 2006 Jul;105(1):51-7. Resumo
45. Gal TJ. Naloxone reversal of buprenorphine-induced respiratory depression. Clin Pharmacol Ther. 1989 Jan;45(1):66-71. Resumo
46. Link HM, Jones H, Miller L, et al. Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2020 Aug;2(3):100179. Resumo
47. Committee Opinion No. 711: Opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017 Aug;130(2):e81-94.Texto completo Resumo
48. The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 2020 Mar/Apr;14(2s 1 suppl):1-91.Texto completo Resumo
49. O'Driscoll BR, Howard LS, Earis J, et al; British Thoracic Society Emergency Oxygen Guideline Group; BTS Emergency Oxygen Guideline Development Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017 Jun;72(suppl 1):ii1-ii90.Texto completo Resumo
50. Purdue Pharma. FDA approves nalmefene HCl injection, 2mg/2mL (1mg/1mL) for the treatment of known or suspected opioid overdose with natural or synthetic opioids. 23 February 2022 [internet publication].Texto completo
51. Olfson M, Crystal S, Wall M, et al. Causes of death after nonfatal opioid overdose. JAMA Psychiatry. 2018 Aug 1;75(8):820-7.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal